Palatin to Report Second Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on February 15, 2023
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fiscal year 2023 operating results on February 15, 2023, before the U.S. market opens. A conference call and live audio webcast will follow the announcement at 11:00 a.m. ET, featuring insights from the executive management team regarding operating results and developmental updates. The press release for the fiscal results will be available at 7:30 a.m. ET on February 15. Investors can access the audio webcast on Palatin's website, providing crucial information about the company's performance and future strategies.
Positive
- Scheduled announcement of Q2 Fiscal Year 2023 results, which could provide insights into revenue and growth metrics.
- Conference call to discuss operating results and developmental updates, offering transparency to investors.
Negative
- None.
Details
News Market Reaction – PTN
The recorded move for PTN in the trading session of this news was -0.60%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast | |
Q2 Fiscal Year 2023 Results Press Release | |
Q2 Fiscal Year 2023 Conference Call-Live | |
US Toll Free Dial-In Number: | 1-888-506-0062 |
International Dial-In Number: | 1-973-528-0011 |
Participant Access Code: | 928705 |
Q2 Fiscal Year 2023 Conference Call-Replay | |
US Toll Free Dial-In Number: | 1-877-481-4010 |
International Dial-In Number: | 1-919-882-2331 |
Participant Access Code: | 47637 |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by accessing this link.
About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-second-quarter-fiscal-year-2023-results-teleconference-and-webcast-to-be-held-on-february-15-2023-301743537.html
SOURCE
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.